Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05990179Not ApplicableRecruiting

Genomic Uniformed-Screening Against Rare Disease In All Newborns

Role: collaborator

NCT06623435Active Not Recruiting

Real World and Genomic Data Based Asthma Insight Through Network Analysis

Role: collaborator

NCT03655223Enrolling By Invitation

Early Check: Expanded Screening in Newborns

Role: collaborator

All 3 trials loaded